T

Tanner Clinic | Research Department

Research site
(Unclaimed)
Location
2121 N 1700 W, Layton, Utah, United States of America

Site insights

Top conditions

Top treatments

Linzagolix
Crisaborole
Hydroxyprogesterone Caproate
dupiluMAb
butoconazole nitrate
Mycophenolic Acid
doxycycline
COL-101
Testosterone
DUPIXENT®

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

6 of 44 total trials

A Dose Escalation Study to Evaluate Safety, Reactogenicity, and Immunogenicity of mRNA-1345 in Healthy Adults and in Children Who Are Respiratory Syncytial Virus (RSV)-Seropositive

The primary objectives of this study are to evaluate the tolerability and reactogenicity of a single injection of up to 5 dose levels of mRNA-1345 in...

Active, not recruiting
Respiratory Syncytial Virus
Drug: Placebo
Biological: mRNA-1345

The main objective of Part A of this trial is to evaluate the safety and reactogenicity of mRNA-1189 in 18- to 30-year-old healthy adults and the mai...

Active, not recruiting
Epstein-Barr Virus Infection
Biological: mRNA-1189
Biological: Placebo

The main purpose of this study is to evaluate the efficacy of mRNA 1647 vaccine in CMV-seronegative female participants and to evaluate the safety an...

Active, not recruiting
Cytomegalovirus Infection
Biological: mRNA-1647
Biological: Placebo

This study is designed to assess post-procedural outcomes for women who chose to undergo either hysteroscopic sterilization (Essure®) or laparoscopic...

Active, not recruiting
Contraception
Device: ESSURE (BAY1454032)
Procedure: Laparoscopic tubal sterilization

Efficacy Study: This randomized, double-blinded, placebo-controlled Phase 3 study is designed to assess the safety, immunogenicity, and efficacy of a...

Enrolling
Lower Respiratory Tract Illness
Biological: Placebo
Biological: RSVpreF

The study will evaluate the safety, tolerability, reactogenicity, and effectiveness of mRNA-1273.214 severe acute respiratory syndrome coronavirus 2...

Enrolling
SARS-CoV-2
Other: Placebo
Biological: mRNA-1273.214

Trial sponsors

Moderna logo
N
Pfizer logo
Abbott logo
AMAG Pharmaceuticals logo
AbbVie logo
Bavarian Nordic logo
B
Exact Sciences Corporation logo
Galderma logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems